Subject: Dividend News:  Imreg Holders Approve Split of Common Stock
Date: Published: 2/18/86 28 lines
Source:  Wall Street Journal.  Copyright Dow Jones & Co. Inc. 

   Dividend News:  
   Imreg Holders Approve
   Split of Common Stock

   NEW ORLEANS -- Imreg Inc. said its stockholders approved
at a special meeting a 2-for-1 split of its Class A and Class
B common shares, payable Feb. 28 to stock of record last
Friday.
   The stock split increased the number of Class A shares
outstanding to 6.3 million and the number of Class B shares
outstanding to four million.
   Holders also approved an increase in the number of
authorized Class A shares to 20 million from 10 million and
the number of Class B to five million from 2.1 million.  Imreg
doesn't pay a quarterly dividend.
   Imreg, which went public in January 1984, researches and
develops drugs to bolster human immune systems, particulary
in victims of acquired immune deficiency syndrome, or AIDS. 

(This article is made available here by Dow Jones Co. for the 
personal and non-commercial use of callers to this bbs, in the 
hope that it will be of some help to those who are suffering 
from the disease and others who are seeking to help them.)